You are here: Home » Current Affairs » Coronavirus » News
IT veteran Ashok Soota sets up non-profit entity for medical research
Adani Ports acquire 25% of Vishwasamudra's stake in Krishnapatnam Port
Business Standard

Serum Institute may apply to sell Covid-19 vaccine Covishield commercially

No Covid vaccine in the world has marketing authorisation allowing sales in private market

Topics
Coronavirus Vaccine | Serum Institute of India | India vaccination

Sohini Das  |  Mumbai 



Covishield
In January, Covishield was allowed a shelf life of six months. This was later extended to nine months, based on the stability data presented by the SII.

The (SII) may apply for ‘marketing authorisation’ for the Covid vaccine Covishield from the Indian drug regulator by the end of April, which will allow it to sell the vaccine commercially.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Mon, April 05 2021. 06:10 IST

RECOMMENDED FOR YOU